Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Predictors and effects of alcohol use on liver function among young HCV-infected injection drug users in a behavioral intervention.

Drumright LN, Hagan H, Thomas DL, Latka MH, Golub ET, Garfein RS, Clapp JD, Campbell JV, Bonner S, Kapadia F, Thiel TK, Strathdee SA.

J Hepatol. 2011 Jul;55(1):45-52. doi: 10.1016/j.jhep.2010.10.028. Epub 2010 Nov 24.

2.

The association between alcohol use and hepatitis C status among injecting drug users in Glasgow.

O'Leary MC, Hutchinson SJ, Allen E, Palmateer N, Cameron S, Taylor A, Goldberg DJ.

Drug Alcohol Depend. 2012 Jun 1;123(1-3):180-9. doi: 10.1016/j.drugalcdep.2011.11.008. Epub 2011 Dec 2.

PMID:
22137645
3.
4.

Progression of liver fibrosis among injection drug users with chronic hepatitis C.

Wilson LE, Torbenson M, Astemborski J, Faruki H, Spoler C, Rai R, Mehta S, Kirk GD, Nelson K, Afdhal N, Thomas DL.

Hepatology. 2006 Apr;43(4):788-95.

PMID:
16557548
5.

Interaction of alcohol and hepatitis C virus infection on severity of liver disease.

Nevins CL, Malaty H, Velez ME, Anand BS.

Dig Dis Sci. 1999 Jun;44(6):1236-42.

PMID:
10389703
6.
7.

Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users.

Pol S, Lamorthe B, Thi NT, Thiers V, Carnot F, Zylberberg H, Berthelot P, Bréchot C, Nalpas B.

J Hepatol. 1998 Jun;28(6):945-50.

PMID:
9672168
8.

HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.

Broz D, Wejnert C, Pham HT, DiNenno E, Heffelfinger JD, Cribbin M, Krishna N, Teshale EH, Paz-Bailey G; National HIV Behavioral Surveillance System Study Group.

MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.

9.

[Efficacy of combined antiviral therapy with pegylated interferon alpha-2a and ribavirin for chronic hepatitis C infection in intravenous drug users].

Ruzić M, Milotka F, Klasnja B, Pobor M, Svarc D, Jovelic A, Fabri I.

Srp Arh Celok Lek. 2010 Jan-Feb;138(1-2):43-9. Serbian.

10.

Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection.

McDonald SA, Hutchinson SJ, Bird SM, Robertson C, Mills PR, Dillon JF, Goldberg DJ.

Int J Drug Policy. 2011 Jan;22(1):63-9. doi: 10.1016/j.drugpo.2010.04.003. Epub 2010 May 15.

PMID:
20472416
11.

Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.

Lirussi F, Beccarello A, Bortolato L, Morselli-Labate AM, Crovatto M, Ceselli S, Santini G, Crepaldi G.

Liver. 1999 Oct;19(5):381-8.

PMID:
10533795
12.

Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.

Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T.

Am J Gastroenterol. 2001 Nov;96(11):3142-6.

PMID:
11721762
13.

Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.

Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R.

Arch Intern Med. 2003 Jan 27;163(2):218-24.

PMID:
12546613
14.

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.

Hepatology. 2001 Dec;34(6):1193-9.

PMID:
11732009
15.

Risk factors for hepatitis C virus infection among homeless adults.

Nyamathi AM, Dixon EL, Robbins W, Smith C, Wiley D, Leake B, Longshore D, Gelberg L.

J Gen Intern Med. 2002 Feb;17(2):134-43.

16.
17.

Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal.

Buechler C, Schäffler A, Johann M, Neumeier M, Köhl P, Weiss T, Wodarz N, Kiefer P, Hellerbrand C.

J Gastroenterol Hepatol. 2009 Apr;24(4):558-63. doi: 10.1111/j.1440-1746.2008.05693.x. Epub 2008 Dec 2.

PMID:
19067777
18.

Efficacy and tolerability of diphenyl-dimethyl-dicarboxylate plus garlic oil in patients with chronic hepatitis.

Lee MH, Kim YM, Kim SG.

Int J Clin Pharmacol Ther. 2012 Nov;50(11):778-86. doi: 10.5414/CP201746.

PMID:
22943930
19.
20.

Lack of behavior change after disclosure of hepatitis C virus infection among young injection drug users in Baltimore, Maryland.

Ompad DC, Fuller CM, Vlahov D, Thomas D, Strathdee SA.

Clin Infect Dis. 2002 Oct 1;35(7):783-8. Epub 2002 Sep 3.

Items per page

Supplemental Content

Write to the Help Desk